<!DOCTYPE html>
<html>
<head>
    <title>How do vac&#xAD;cines work? - PressReader</title>
    <meta name="description" content="">
    <meta content="magazines, newspapers, digital news, reading, news, breaking news, newspaper online" name="keywords">
    <meta name="Robots" content="NOARCHIVE,NOODP">
    <meta charset="UTF-8">
    <meta http-equiv="Content-type" content="text/html; charset=utf-8" />
    <meta name="viewport" content="width=device-width, initial-scale=1" />
    
    <link rel="canonical" href="/singapore/the-straits-times/20210109/281986085189073" />


    <style>
        li {
            margin: 1em 0;
        }
        img {
            max-width: 100%;
        }
        p, h1, h2, h3 {
            max-width: 100%;
        }
    </style>
</head>
<body>
    <div>
        

<article>
    <h1>How do vac&#xAD;cines work?</h1>
    <h2></h2>
    <section>
        <a href="/singapore/the-straits-times/textview" title="The Straits Times">The Straits Times</a>
        - <a href="/singapore/the-straits-times/20210109/textview" title="The Straits Times - 2021-01-09"><time>2021-01-09</time></a>
        - <span>NEWS FOCUS INSIGHT</span>
        - <span role="byline">Au&#xAD;drey Tan&#xD;&#xA;Sci&#xAD;ence Cor&#xAD;re&#xAD;spon&#xAD;dent au&#xAD;dreyt@sph.com.sg</span>
    </section>

    <p>Q How do vac­cines work?</p>
    <p>A Vac­cines work by “show­ing” the im­mune sys­tem an im­por­tant part of a virus and “train­ing” it to recog­nise and re­mem­ber the pathogen with­out ex­pos­ing the pa­tient to the risk of dis­ease.</p>
    <p>Tra­di­tional vac­cines do this by in­ject­ing a killed or weak­ened form of a virus into the hu­man body, so the im­mune sys­tem recog­nises the in­vader and be­gins sum­mon­ing its “sol­diers” – an­ti­bod­ies and T-cells – to get rid of it.</p>
    <p>But mRNA vac­cines like the Covid-19 ones by Pfizer-BioNTech and Moderna are dif­fer­ent in that they con­tain only frag­ments of the virus’ ge­netic ma­te­rial, in­stead of the whole virus.</p>
    <p>When these vi­ral ge­netic frag­ments en­ter the hu­man cell af­ter in­jec­tion, the genome frag­ments com­man­deer the cell to be­gin pro­duc­ing the sig­na­ture spike pro­tein of the coro­n­avirus.</p>
    <p>This trains the body to recog­nise a key part of the virus – the spike pro­tein – with­out ex­pos­ing the pa­tient to the whole virus.</p>
    <p>Q Is China’s Si­no­vac also de­vel­op­ing an mRNA vac­cine?</p>
    <p>A No. The Si­no­vac vac­cine is an in­ac­ti­vated vac­cine, a plat­form that has been used in many other shots, such as the po­lio vac­cine.</p>
    <p>The coro­n­avirus was first grown in mon­key kid­ney cells, and then doused with a chem­i­cal that in­ac­ti­vated them, re­ported The New York Times.</p>
    <p>This meant the viruses could no longer repli­cate, even though their pro­teins, in­clud­ing the spike pro­tein, re­mained in­tact.</p>
    <p>The in­ac­ti­vated viruses were then mixed with ad­ju­vants, which are in­gre­di­ents used to stim­u­late the im­mune sys­tem to boost its re­sponse to a vac­cine.</p>
    <p>Q What are the lat­est up­dates for the Covid-19 vac­cine be­ing de­vel­oped in Sin­ga­pore?</p>
    <p>A Re­searchers from Duke-NUS Med­i­cal School are working with Amer­i­can biotech­nol­ogy com­pany Arc­turus Ther­a­peu­tics to de­velop an mRNA vac­cine against Covid-19.</p>
    <p>This is sim­i­lar to the can­di­dates be­ing de­vel­oped by Moderna and Pfizer-BioNTech, with one dif­fer­ence: The Lu­nar-Cov19 mRNA mol­e­cule is a repli­cat­ing one that makes mul­ti­ple copies of the vi­ral spike pro­tein af­ter the in­jec­tion.</p>
    <p>The mol­e­cules in the other two vac­cines are non-repli­cat­ing.</p>
    <p>Re­searchers told The Straits Times ear­lier that the repli­ca­tion more closely mim­ics how a vi­ral in­fec­tion plays out in the body, and could coax a stronger im­mune re­sponse from the body.</p>
    <p>Early-phase clin­i­cal tri­als are still on­go­ing in Sin­ga­pore.</p>
    <p>The SingHealth In­ves­ti­ga­tional</p>
    <p>Medicine Unit, which is ad­min­is­ter­ing the tri­als, is re­cruit­ing 100 healthy adult vol­un­teers aged 21 years or older for this next phase of test­ing.</p>
    <p>Those in­ter­ested can e-mail imu@singhealth.com.sg or call 6323-7544 or 8318-0685.</p>


</article>

<section>
    <h3><a href="/catalog/language/english">Newspapers in English</a></h3>
    <h3><a href="/catalog/country/singapore">Newspapers from Singapore</a></h3>
</section>

    </div>
    
    <p><a href="http://www.pressreader.com">© PressReader. All rights reserved.</a></p>

        <script>
            (function (i, s, o, g, r, a, m) {
                i['GoogleAnalyticsObject'] = r; i[r] = i[r] || function () {
                    (i[r].q = i[r].q || []).push(arguments);
                }, i[r].l = 1 * new Date();
                a = s.createElement(o), m = s.getElementsByTagName(o)[0]; a.async = 1; a.src = g;
                m.parentNode.insertBefore(a, m);
            })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
        </script>
        <script>
            ga('create', 'UA-44408245-1');
            ga('send', 'pageView');
        </script>
</body>
</html>
